View company's website
Copenhagen, DK · 1 known investors
Novo Nordisk is a pharmaceutical company that develops and markets treatments for diabetes, hemophilia, weight management, and other chronic diseases through innovative drug therapies.
BiotechHealthtechMedical Devices